{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:08:26Z","timestamp":1788581306830,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Carl Zeiss Vision"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myopia prevalence has been increasing in the last decades, and its pathological consequences, including myopic maculopathy and high myopia-associated optic neuropathy, are now one of the most common causes of visual impairment. It is estimated that by 2050, more than 50% of Europeans and Americans will be myopes, which is alarming due to the high morbidity of myopes over\u2009\u2212\u20096.00D. Once myopia has appeared, there are different options with scientific evidence to try to slow the axial length growth. Ophthalmic lenses are the less invasive treatment to control myopia, and there is evidence about the efficacy of different designs, mainly in the Asiatic population. However, new designs have been launched, and it is not known if efficacy is the same between Asiatic and European subjects. Thus, we have set up a randomized, controlled, double-blind, and multicenter trial to investigate the efficacy of a new design of ophthalmic lenses for myopia control in European children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A 2-year prospective, multicenter, randomized controlled, and double-blind clinical trial is used to investigate the efficacy of a new design of ophthalmic lenses to slow the progression of myopia. Three hundred children aged from 6 to 13\u00a0years old will be recruited and randomly assigned to a study or control group. The study group will be composed of 150 children wearing MyoCare while the control group will be composed of 150 children wearing Clearview. The inclusion criteria will be myopia with a spherical equivalent between\u2009\u2212\u20090.75D and\u2009\u2212\u20095.00D, astigmatism\u2009&lt;\u20091.50D, and anisometropia\u2009&lt;\u20091.00D and having a historical evolution of at least\u2009\u2212\u20090.50 The primary outcome is to compare the mean annual progression of the spherical equivalent between both groups. The secondary outcomes are axial length, choroidal thickness, phorias, and accommodative status of both groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study will be the first randomized and controlled clinical trial in European children with spectacle lenses based on simultaneous competing defocus. The results will shed light on the clinical evidence of spectacle lenses relying on this new design for the management of myopia with results of efficacy in the non-Asiatic population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>EU Clinical Trials Register (EudraCT) 2022\u2013001696. Registered on 27 April 2022. ClinicalTrials.gov NCT05919654. Registered on 26 June 2023.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07696-0","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T07:04:30Z","timestamp":1697526270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical Evaluation of MyoCare in Europe (CEME): study protocol for a prospective, multicenter, randomized, double-blinded, and controlled clinical trial"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1097-4581","authenticated-orcid":false,"given":"Cristina","family":"Alvarez-Peregrina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2583-1789","authenticated-orcid":false,"given":"Miguel Angel","family":"Sanchez-Tena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0996-5007","authenticated-orcid":false,"given":"Clara","family":"Martinez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6743-8264","authenticated-orcid":false,"given":"Cesar","family":"Villa-Collar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Clinical Evaluation of MyoCare in Europe \u2013the CEME Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Montero-Torrejon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Lopez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Ruiz-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Isabel","family":"Gonzalez-Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Manuel","family":"Santos-de-Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"de Corcuera Terrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Gargallo-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Mataix-Palao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Boeck-Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Asensio","family":"Celdran-Vivancos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Vega-Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Manuel","family":"Martinho-Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Carlos","family":"Garay-Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ignacio","family":"Recalde-Zurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"Reina-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"L\u00e9rida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Gonzalez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Silva-Carrola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Alves-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Gutierrez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Blanco-Cotovio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul Manuel","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Kratzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimiro","family":"Oliveira-Hip\u00f3lito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6373-1420","authenticated-orcid":false,"given":"Arne","family":"Ohlendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"7696_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1167\/iovs.61.4.49","volume":"61","author":"AEG Haarman","year":"2020","unstructured":"Haarman AEG, Enthoven CA, Willem Tideman JL, Tedja MS, Verhoeven VJM, Klaver CCW. The complications of myopia: a review and meta-analysis. Invest Ophthalmol Vis Sci. 2020;61:49.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7696_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123:1036\u201342.","journal-title":"Ophthalmology"},{"key":"7696_CR3","doi-asserted-by":"publisher","first-page":"1004977","DOI":"10.1155\/2022\/1004977","volume":"2022","author":"A Russo","year":"2022","unstructured":"Russo A, Boldini A, Romano D, Mazza G, Bignotti S, Morescalchi F, et al. Myopia: mechanisms and strategies to slow down its progression. J Ophthalmol. 2022;2022:1004977.","journal-title":"J Ophthalmol"},{"key":"7696_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2017.09.004","volume":"62","author":"IG Morgan","year":"2018","unstructured":"Morgan IG, French AN, Ashby RS, Guo X, Ding X, He M, et al. The epidemics of myopia: aetiology and prevention. Prog Retin Eye Res. 2018;62:134.","journal-title":"Prog Retin Eye Res"},{"key":"7696_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.64.6.6","volume":"64","author":"JS Wolffsohn","year":"2023","unstructured":"Wolffsohn JS, Whayeb Y, Logan NS, Weng R. IMI\u2014global trends in myopia management attitudes and strategies in clinical practice\u20142022 update. Invest Opthalmol Visual Sci. 2023;64:6.","journal-title":"Invest Opthalmol Visual Sci"},{"key":"7696_CR6","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.ophtha.2022.06.024","volume":"129","author":"X He","year":"2022","unstructured":"He X, Sankaridurg P, Wang J, Chen J, Naduvilath T, He M, et al. Time outdoors in reducing myopia: a school-based cluster randomized trial with objective monitoring of outdoor time and light intensity. Ophthalmology. 2022;129:1245.","journal-title":"Ophthalmology"},{"key":"7696_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ophtha.2021.10.016","volume":"129","author":"A Ha","year":"2022","unstructured":"Ha A, Kim SJ, Shim SR, Kim YK, Jung JH. Efficacy and safety of 8 atropine concentrations for myopia control in children: a network meta-analysis. Ophthalmology. 2022;129:322.","journal-title":"Ophthalmology"},{"key":"7696_CR8","first-page":"157","volume":"7","author":"R Kaiti","year":"2022","unstructured":"Kaiti R. Role of atropine in the control of myopia progression- a review. Beyoglu Eye J. 2022;7:157.","journal-title":"Beyoglu Eye J"},{"key":"7696_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/iovs.63.10.17","volume":"63","author":"DO Mutti","year":"2022","unstructured":"Mutti DO, Sinnott LT, Berntsen DA, Jones-Jordan LA, Orr DJ, Walline JJ. The effect of multifocal soft contact lens wear on axial and peripheral eye elongation in the BLINK study. Invest Ophthalmol Vis Sci. 2022;63:17.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7696_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/OPTH.S338199","volume":"16","author":"A Malinowski","year":"2022","unstructured":"Malinowski A, Mrugacz M, Stopa M, Filipek E, Moniuszko-Malinowska A, Czupryna P. A clinical study of the impact of soft contact lenses on the progression of myopia in young patients. Clin Ophthalmol. 2022;16:51.","journal-title":"Clin Ophthalmol"},{"key":"7696_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/OPX.0000000000001873","volume":"99","author":"P Chamberlain","year":"2022","unstructured":"Chamberlain P, Bradley A, Arumugam B, Hammond D, McNally J, Logan NS, et al. Long-term effect of dual-focus contact lenses on myopia progression in children: a 6-year multicenter clinical trial. Optome Vis Sci. 2022;99:204.","journal-title":"Optome Vis Sci"},{"key":"7696_CR12","doi-asserted-by":"publisher","first-page":"100232","DOI":"10.1016\/j.xops.2022.100232","volume":"3","author":"X Cheng","year":"2023","unstructured":"Cheng X, Xu J, Brennan NA. Randomized trial of soft contact lenses with novel ring focus for controlling myopia progression. Ophthalmol Sci. 2023;3:100232.","journal-title":"Ophthalmol Sci"},{"key":"7696_CR13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/cxo.12839","volume":"102","author":"P Cho","year":"2019","unstructured":"Cho P, Tan Q. Myopia and orthokeratology for myopia control. Clin Exp Optom. 2019;102:364.","journal-title":"Clin Exp Optom"},{"key":"7696_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.clae.2021.02.003","volume":"44","author":"SJ Vincent","year":"2021","unstructured":"Vincent SJ, Cho P, Chan KY, Fadel D, Ghorbani-Mojarrad N, Gonz\u00e1lez-M\u00e9ijome JM, et al. CLEAR - orthokeratology. Contact Lens Anterior Eye. 2021;44:240.","journal-title":"Contact Lens Anterior Eye"},{"key":"7696_CR15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","volume":"123","author":"J Huang","year":"2016","unstructured":"Huang J, Wen D, Wang Q, McAlinden C, Flitcroft I, Chen H, et al. Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis. Ophthalmology. 2016;123:697.","journal-title":"Ophthalmology"},{"key":"7696_CR16","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.1167\/iovs.12-11462","volume":"55","author":"S Hasebe","year":"2014","unstructured":"Hasebe S, Jun J, Varnas SR. Myopia control with positively aspherized progressive addition lenses: a 2-year, multicenter, randomized, controlled trial. Invest Ophthalmol Vis Sci. 2014;55:7177.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7696_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/jov.23.3.3","volume":"23","author":"SR Varnas","year":"2023","unstructured":"Varnas SR, Kaphle D, Schmid KL, Suheimat M, Atchison DA. Effect of multifocal spectacle lenses on accommodative errors over time: possible implications for myopia control. J Vis. 2023;23:3.","journal-title":"J Vis"},{"key":"7696_CR18","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.18240\/ijo.2022.10.20","volume":"15","author":"JX Ma","year":"2022","unstructured":"Ma JX, Tian SW, Liu QP. Effectiveness of peripheral defocus spectacle lenses in myopia control: a meta-analysis and systematic review. Int J Ophthalmol. 2022;15:1699.","journal-title":"Int J Ophthalmol"},{"key":"7696_CR19","first-page":"20","volume":"6","author":"MM Carl\u00e0","year":"2022","unstructured":"Carl\u00e0 MM, Boselli F, Giannuzzi F, Gambini G, Caporossi T, De Vico U, et al. Overview on defocus incorporated multiple segments lenses: a novel perspective in myopia progression management. Vision (Switzerland). 2022;6:20.","journal-title":"Vision (Switzerland)"},{"key":"7696_CR20","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.3390\/jcm11092294","volume":"11","author":"H Zhang","year":"2022","unstructured":"Zhang H, Lam CSY, Tang WC, Leung M, Qi H, Lee PH, et al. Myopia control effect is influenced by baseline relative peripheral refraction in children wearing defocus incorporated multiple segments (DIMS) spectacle lenses. J Clin Med. 2022;11:2294.","journal-title":"J Clin Med"},{"key":"7696_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1167\/iovs.61.5.53","volume":"61","author":"HY Zhang","year":"2020","unstructured":"Zhang HY, Lam CSY, Tang WC, Leung M, To CH. Defocus incorporated multiple segments spectacle lenses changed the relative peripheral refraction: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2020;61:53.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7696_CR22","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1167\/iovs.16-19704","volume":"57","author":"B Arumugam","year":"2016","unstructured":"Arumugam B, Hung LF, To CH, Sankaridurg P, Smith EL. The effects of the relative strength of simultaneous competing defocus signals on emmetropization in infant rhesus monkeys. Invest Ophthalmol Vis Sci. 2016;57:3949.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7696_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.visres.2020.08.003","volume":"177","author":"EL Smith","year":"2020","unstructured":"Smith EL, Arumugam B, Hung LF, She Z, Beach K, Sankaridurg P. Eccentricity-dependent effects of simultaneous competing defocus on emmetropization in infant rhesus monkeys. Vis Res. 2020;177:32.","journal-title":"Vis Res"},{"key":"7696_CR24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/OPX.0000000000001410","volume":"96","author":"P Chamberlain","year":"2019","unstructured":"Chamberlain P, Peixoto-De-Matos SC, Logan NS, Ngo C, Jones D, Young G. A 3-year randomized clinical trial of MiSight lenses for myopia control. Optom Vis Sci. 2019;96:556.","journal-title":"Optom Vis Sci"},{"key":"7696_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12886-017-0639-4","volume":"17","author":"YC Lee","year":"2017","unstructured":"Lee YC, Wang JH, Chiu CJ. Effect of Orthokeratology on myopia progression: twelve-year results of a retrospective cohort study. BMC Ophthalmol. 2017;17:243.","journal-title":"BMC Ophthalmol"},{"key":"7696_CR26","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1097\/OPX.0000000000000038","volume":"90","author":"EL Smith","year":"2013","unstructured":"Smith EL, Hung LF, Huang J, Arumugam B. Effects of local myopic defocus on refractive development in monkeys. Optom Vis Sci. 2013;90:1176.","journal-title":"Optom Vis Sci"},{"key":"7696_CR27","doi-asserted-by":"publisher","first-page":"3419576","DOI":"10.1155\/2019\/3419576","volume":"2019","author":"CC Alvarez-Peregrina","year":"2019","unstructured":"Alvarez-Peregrina CC, Sanchez-Tena MAMA, Martinez-Perez CC, Villa-Collar CC. Prevalence and risk factors of myopia in Spain. J Ophthalmol. 2019;2019:3419576.","journal-title":"J Ophthalmol"},{"key":"7696_CR28","doi-asserted-by":"publisher","first-page":"12375","DOI":"10.3390\/ijerph182312375","volume":"18","author":"C Alvarez-Peregrina","year":"2021","unstructured":"Alvarez-Peregrina C, Martinez-Perez C, Villa-Collar C, Gonz\u00e1lez-P\u00e9rez M, Gonz\u00e1lez-Abad A, S\u00e1nchez-Tena M\u00c1. The prevalence of myopia in children in Spain: an updated study in 2020. Int J Environ Res Public Health. 2021;18:12375.","journal-title":"Int J Environ Res Public Health"},{"key":"7696_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100923","volume":"83","author":"NA Brennan","year":"2021","unstructured":"Brennan NA, Toubouti YM, Cheng X, Bullimore MA. Efficacy in myopia control. Prog Retin Eye Res. 2021;83: 100923.","journal-title":"Prog Retin Eye Res"},{"key":"7696_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40662-022-00276-4","volume":"9","author":"M Xu","year":"2022","unstructured":"Xu M, Yu X, Wan M, Feng K, Zhang J, Shen M, et al. Two-year longitudinal change in choroidal and retinal thickness in school-aged myopic children: exploratory analysis of clinical trials for myopia progression. Eye Vis. 2022;9:5.","journal-title":"Eye Vis"},{"key":"7696_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2020","unstructured":"Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, et al. Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104:363.","journal-title":"Br J Ophthalmol"},{"key":"7696_CR32","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s40123-023-00671-7","volume":"12","author":"W Wang","year":"2023","unstructured":"Wang W, Jiang Y, Zhu Z, Zhang S, Xuan M, Tan X, et al. Axial shortening in myopic children after repeated low-level red-light therapy: post hoc analysis of a randomized trial. Ophthalmol Ther. 2023;12:1223\u201337.","journal-title":"Ophthalmol Ther"},{"key":"7696_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/ICU.0000000000000647","volume":"31","author":"RRA Bourne","year":"2020","unstructured":"Bourne RRA. Vision 2020: where are we? Curr Opin Ophthalmol. 2020;31:81.","journal-title":"Curr Opin Ophthalmol"},{"key":"7696_CR34","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","volume":"9","author":"RRA Bourne","year":"2021","unstructured":"Bourne RRA, Steinmetz JD, Saylan M, Mersha AM, Weldemariam AH, Wondmeneh TG, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: n analysis for the global burden of disease study. Lancet Glob Health. 2021;9:e144.","journal-title":"Lancet Glob Health"},{"key":"7696_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/iovs.62.5.5","volume":"62","author":"K Ohno-Matsui","year":"2021","unstructured":"Ohno-Matsui K, Wu PC, Yamashiro K, Vutipongsatorn K, Fang Y, Cheung CMG, et al. IMI pathologic myopia. Invest Ophthalmol Vis Sci. 2021;62:5.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07696-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07696-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07696-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T05:27:08Z","timestamp":1700371628000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07696-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7696"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07696-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2948213\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"29 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Medical Ethics Research Committee of Hospital Cl\u00ednico San Carlos, Madrid, Spain (approval number 22\/384-EC_P). The study has been also registered in the EU Clinical Trials Register on 27 April 2022 (EudraCT: 2022\u2013001696) and in ClinicalTrials.gov (ID NCT05919654), published on 26 June 2023:\n                      \n                      .Written, informed consent to participate will be obtained from all the parents, and an additional informed consent will be signed by the participants older than 12\u00a0years old.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable.All the data from the participants will be anonymized for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"674"}}